CHA Bio Group head outlines vision for stem cells to fight diseases, extend life
Dr. Cha Kwang-yul, head of the CHA Global Research Institutes at CHA Medical Center and CHA Bio Group, outlined an ambitious vision to use stem cells to treat intractable diseases and potentially extend human lifespan, drawing global interest at an international conference in Busan. Cha delivered his keynote address, titled "Longevity and Reproductive Aging Using K-Cells," at the 16th World…
Dr. Cha Kwang-yul, the leader of the CHA Global Research Institutes at CHA Medical Center and CHA Bio Group, presented an ambitious plan to utilize stem cells for treating difficult diseases and possibly increasing human lifespan at a major international gathering in Busan. The address, given as the keynote titled "Longevity and Reproductive Aging Using K-Cells," was delivered during the 16th World Congress of the International Society for Immunology of Reproduction, which was attended by approximately 400 people.
The presentation centered on K-Cell, a proposed cell source designed to aid in creating therapies for difficult conditions before shifting focus to aging and longevity research. Dr. Cha outlined a method for selecting donors based on their medical and infectious disease histories, age, clinical traits, medical histories of three generations of their family, and whole-genome sequencing to pinpoint cells appropriate for specific therapeutic uses.
He also delved into genetic modification and somatic cell nuclear transfer, a method that involves transferring the nucleus of a cell from one organism into an enucleated ovum from another organism.
Written by urgent.news from The Korea Times's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
This story
This is one outlet's version. Read the fullest account.
